Le Lézard
Classified in: Health
Subjects: LBR, AVO

MNA: Nearly 100% of Brigham and Women's Hospital OR and PACU Nurses Sign Petition Calling for the Removal of VP of Perioperative Services for Putting Patient Care at Risk and Demoralizing Nurses


Surgical and post-surgical patients are experiencing unsafe and uncomfortable care environments as BWH's perioperative leadership refuses to address nurses' concerns

BOSTON, Aug. 1, 2023 /PRNewswire/ -- Almost every operating room (OR) and post-anesthesia care (PACU) registered nurse at Brigham and Women's Hospital has signed a petition of no confidence in Vice President of Perioperative Services Samantha Rowley, demanding her removal due to a series of decisions that have undermined the safety and quality of care provided to surgical and post-surgical patients and caused high turnover because of a culture of management bullying and retaliation.

The petition was delivered to the BWH Senior Vice President, Patient Care Services, and Chief Nursing Officer, as well as the Vice President, Human Resources, Patient Care Services and Operational Excellence on Monday, July 31. It was signed by 131 of 132 regularly scheduled OR nurses of nurses and 120 out of 124 PACU and perioperative float pool nurses. The nurses gave hospital management notice of the petition several days before delivering it, but so far, the hospital has refused to act.

"We, the registered nurses of Brigham and Women's Hospital, declare no confidence in Vice President of Perioperative Services Samantha Rowley for a series of damaging decisions that have jeopardized patient safety, degraded our work environment, and made it even harder to retain staff," the nurses wrote in their petition. "A change in senior management is necessary to stop the ongoing harm to patients and caregivers. The hospital must work with us to immediately address these problems. It must place patients and staff above profits."

Specific issues nurses included in their petition:

"We need leadership overseeing the OR and PACU that listens to nurses and makes decisions that maintain patient care excellence," said Jim Mccarthy, a PACU nurse and BWH MNA Vice Chair. "We are losing nurses because of the harmful decisions being made by current perioperative leadership and patients are feeling the negative effects. Brigham patients and nurses deserve new leadership that puts our needs above corporate profits."

"When BWH leadership changed nurse scheduling in the OR, completely disregarding our concerns, we lost nurses and patient care conditions got worse," said Sandra Abber, an OR nurse and member of the BWH MNA Bargaining Committee. "Brigham and Women's Hospital continues to charge ahead scheduling as many surgeries as possible even when we have insufficient staff to perform them safely. We need perioperative leadership that understands and cares about what is happening at the bedside."

MassNurses.org ? Facebook.com/MassNurses ? Twitter.com/MassNurses ? Instagram.com/MassNurses 

Founded in 1903, the Massachusetts Nurses Association is the largest union of registered nurses in the Commonwealth of Massachusetts. Its 25,000 members advance the nursing profession by fostering high standards of nursing practice, promoting the economic and general welfare of nurses in the workplace, projecting a positive and realistic view of nursing, and by lobbying the Legislature and regulatory agencies on health care issues affecting nurses and the public.

SOURCE Massachusetts Nurses Association


These press releases may also interest you

at 00:01
America's child care supply remains flat, while child care prices continue to increase, according to a new report released today by Child Care Aware® of America (CCAoA) that highlights the burden families face accessing quality and affordable child...

at 00:01
The cost of living is Gen Zs' and millennials' top societal concern, but green shoots of optimism for the economy and their personal finances are emergingNearly nine in 10 Gen Zs and millennials say purpose is important to their job satisfaction and...

at 00:00
AmacaThera Inc, a clinical stage biotechnology company specializing in the development of advanced sustained release hydrogel formulations, has dosed its first human subject with AMT-143, the company's lead asset in non-opioid acute pain management. ...

14 mai 2024
BioArctic AB's (publ) partner Eisai today said that they expect Leqembi sales to total JPY 56.5 billion (approximately SEK 4 billion) for their fiscal year (FY) 2024 (April 2024 through March 2025). This would generate approximately SEK 360 M in net...

14 mai 2024
The global flow cytometry market  size is estimated to grow by USD 6038.44 million from 2023-2027, according to Technavio. The market is estimated to grow at a CAGR of about 13.12%  during the forecast period....

14 mai 2024
BioArctic AB's (publ) partner Eisai announced today that they have initiated the rolling submission of a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for lecanemab-irmb (U.S. brand name: Leqembi) subcutaneous...



News published on and distributed by: